13/03/25
Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022
Matilda Berkell, Anna Górska, Mathias Smet, Delphine Bachelet, Elisa Gentilotti, Mariana Guedes, Anna Maria Franco-Yusti, Fulvia Mazzaferri, Erley Lizarazo Forero, Veerle Matheeussen, Benoit Visseaux, Zaira R. Palacios-Baena, Natascia Caroccia, Aline-Marie Florence, Charlotte Charpentier, Coretta van Leer, Maddalena Giannella, Alex W. Friedrich, Jesús Rodríguez-Baño, Jade Ghosn, ORCHESTRA working group, Samir Kumar-Singh, Cedric Laouénan, Evelina Tacconelli, Surbhi Malhotra-Kumar
Background: Evolution of SARS-CoV-2 is continuous.
Aim: Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity.
Methods: In nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined. Patients’ demographic and clinical details were recorded. Associations between mild/moderate or severe COVID-19 and SARS-CoV-2 variants and patient characteristics were assessed by logistic regression. Rates and genomic locations of mutations, as well as quasi-species distribution (≥ 2 heterogeneous positions, ≥ 50× coverage) were estimated based on 1,332 high-quality sequences.
Results: Overall, 11 SARS-CoV-2 clades infected 1,762 study patients of median age 59 years (interquartile range (IQR): 45–73), with 52.5% (n = 925) being male. In total, 101 non-synonymous substitutions/insertions correlated with disease prognosis (severe, n = 27; mild-to-moderate, n = 74). Several hotspots (mutation rates ≥ 85%) occurred in Alpha, Delta, and Omicron variants of concern (VOCs) but none in pre-Alpha strains. Four hotspots were retained across all study variants, including spike:D614G. Average number of mutations per open-reading-frame (ORF) increased in the spike gene (average < 5 per genome in January 2020 to > 15 in 2022), but remained stable in ORF1ab, membrane, and nucleocapsid genes. Quasi-species were most prevalent in 20A/EU2 (48.9%), 20E/EU1 (48.6%), 20A (38.8%), and 21K/Omicron (36.1%) infections. Immunocompromised status and age (≥ 60 years), while associated with severe COVID-19 or death irrespective of variant (odds ratio (OR): 1.60–2.25; p ≤ 0.014), did not affect quasi-species’ prevalence (p > 0.05).
Conclusion: Specific mutations correlate with COVID-19 severity. Quasi-species potentially shaping VOCs’ emergence are relevant to consider.